Oregon Public Employees Retirement Fund Uni Qure N.V. Transaction History

Oregon Public Employees Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	SELL	$11.12 - $22.2 $2,224 - $4,440	-200 Reduced 1.51%	13,081 $149,000
Q1 2023 May 04, 2023	SELL	$18.7 - $23.07 $7,741 - $9,550	-414 Reduced 3.02%	13,281 $267,000
Q4 2022 Jan 26, 2023	BUY	$18.12 - $27.32 $906 - $1,366	50 Added 0.37%	13,695 $0
Q3 2022 Nov 01, 2022	BUY	$16.98 - $25.54 $29,103 - $43,775	1,714 Added 14.37%	13,645 $256,000
Q2 2022 Jul 25, 2022	SELL	$13.15 - $20.45 $19,619 - $30,511	-1,492 Reduced 11.12%	11,931 $222,000
Q1 2022 Apr 21, 2022	SELL	$14.54 - $21.5 $5,816 - $8,600	-400 Reduced 2.89%	13,423 $243,000
Q4 2021 Feb 01, 2022	SELL	$20.24 - $36.01 $12,143 - $21,606	-600 Reduced 4.16%	13,823 $287,000
Q3 2021 Oct 19, 2021	BUY	$26.01 - $38.22 $375,142 - $551,247	14,423 New	14,423 $462,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.